Chair: S. Engelhardt (München), T. Eschenhagen (Hamburg)
| (V514) | Altered miRNA binding as a cause of disease |
| Y. M. Pinto (Amsterdam, NL) | |
| (V515) | Micro RNA as therapeutic targets |
| T. Thum (Hannover) | |
| (V516) | RNA-based correction of gene defects in HCM |
| L. Carrier (Hamburg) | |
| (V517) | AAV-vectors to target the heart |
| O. J. Müller (Heidelberg) |